Article: FDA issues draft guidelines on drug-eluting stents.(Medical Devices)

FDA Commissioner Andrew von Eschenbach announced March 31 that the agency has issued draft guidelines to aid the development, testing and manufacture of coronary drug-eluting stents, devices used to treat blocked heart arteries.

Over the past few years, FDA and the clinical community have been closely monitoring these devices, including concerns over clot formation in some patients several years after implantation, the agency announced. The draft guidelines issued outline FDA's recommendations for pre-market clinical evaluation and post-market studies, "which may provide data to better address this and other potential safety concerns."

In its most rigorous ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!